Bill > HB3286

This bill aims to enhance prescription drug benefits under Medicaid and the child health plan program in Texas. Key provisions include: 1. Requiring the Texas Health and Human Services Commission (HHSC) to ensure the Medicaid vendor drug program includes all drugs available under the federal Medicaid Drug Rebate Program, either after approval or during a provisional 90-day review period. 2. Allowing exceptions to the Medicaid preferred drug list in certain circumstances, such as if the required drug is contraindicated or ineffective for the patient. 3. Requiring HHSC to develop an expedited review process for adding drugs to the preferred drug list and grant temporary non-preferred status to new drugs pending review. 4. Modifying the composition of the Drug Utilization Review Board to include more representatives from managed care organizations, who must be physicians or pharmacists. The bill also includes provisions to ensure compliance with federal Medicaid requirements and authorizes a delay in implementation if state agencies determine a federal waiver or authorization is necessary.